ENW-Masthead2.gif (25553 bytes)

bar_Turquoise_and_Gray.jpg (1480 bytes)

Research Applied to Clinical Practiceimgtchr1.gif (1235 bytes)
by Robert C. Knies, RN MSN CEN
Section Editor

bar_Turquoise_and_Gray.jpg (1480 bytes)
International Normalized Ratio (INR)
bar_Turquoise_and_Gray.jpg (1480 bytes)

    More than 2 million Americans are estimated to be treated with warfarin (National Center for Statistics, 1984). As with any medical treatment the weighing of risks and benefits must be carefully balanced. Anticoagulation agents have a narrow therapeutic index, and the more narrow the therapeutic index, the greater the chance for adverse effects, i.e., bleeding (Ortel, 1995). To achieve optimal effects and evaluate the patient's response to warfarin, the clinician must keep in mind several important concepts. First, the intensity and duration of the therapy depends on the identified need for treatment. Second, the dose of warfarin must be patient specific, and lastly, periodic assessment of effectiveness is necessary due to warfarin's narrow therapeutic index. Considering the aforementioned facts, the blood test chosen to monitor the patient's response to warfarin must be accurate, reliable and cost effective (Ortel, 1995).

    The traditional method of determining the efficacy of anticoagulation therapy is the prothrombin time (PT). This was first described by Armand J. Quick in 1935. He used thromboplastin derived from rabbit brains to prove his assumption that patients with bleeding abnormalities secondary to obstructive jaundice was due to a deficiency of prothrombin. This is now know to result from reduced levels of liver-produced vitamin K-dependent blood coagulation factors II, IX, and X (Florell & Rodgers, 1996).

    Today a blood sample is collected in a tube containing citrated sodium, in the laboratory the sample is spun in a centrifuge, and a specific volume of thromboplastin reagent is added to the sample. The time until a fibrin clot forms, measured in seconds, is reported as the PT (Ortel, 1995). The thromboplastin reagent can be either an extract of mammalian tissue (lungs heart or brain of animals) rich in tissue factor, or a recombinant proportion of human tissue factor in combination with phospholipids (Hirsh & Poller, 1994).

    Because thromboplastins are produced using different methods and from different sources, the sensitivity of an individual thromboplastin to another can vary greatly. The more sensitive the thromboplastin reagent the longer the resulting PT. Conversely, the less sensitive the reagent the shorter the resulting PT. Variance can even occur within a single batch depending on shelf time (Ortel, 1995). This variability in sensitivity and its effect on PT outcomes can have a major detrimental effects on the management of warfarin therapy in patients requiring anticoagulation. This variability has also caused great international debate and concern for several decades (Florell & Rodgers, 1996).

    To help standardize this difference two formats were developed, the first was the International Sensitivity Index (ISI) and the second was the International Normalized Ratio (INR). The INR was developed to incorporate the ISI values and attempt to make PT results uniformly useable. The manufacturers assign an ISI to each batch of reagent after comparing each batch to a "working reference" reagent preparation. This "working reference" has been calibrated against internationally accepted standard reference preparations which have an ISI value of 1.0 (Ortel, 1995). By definition, the more sensitive thromboplastin have an ISI of less than 1.0 and the less sensitive are greater than 1.0. The ISI value is critical for calculation of the INR, because the ISI value is the exponent in the formula. Consequently, small errors in the ISI assignment may affect the calculated INR substantially (Florell & Rodgers, 1996).

    To resolve the problem of highly variable PTs, the use of the INR has been recommended for monitoring patient's oral anticoagulant therapy. This recommendation is supported by the American College of Chest Physicians, the National Heart, Lung and Blood Institute and the British Society for Hematology (Nichols & Bowie, 1993).

    It is important to emphasize that the INR is not a new laboratory test. It is simply a mathematical calculation that corrects for the variability in PT results attributable to the variable sensitivities (ISI) of the thromboplastin agents used by laboratories.

INR = - patient PT______ ISI

OR

INR = {PTR}ISI

Mean normal PT

PTR- is the prothrombin time ratio, which is the patient's observed PT (in seconds) divided by each laboratory's calculated mean normal PT (in seconds) (Ortel, 1995, Florell & Rodgers, 1996).

    A target INR range of 2.0 to 3.0 is recommended for most indications, such as treatment or prophylaxis of DVT, prevention of further clotting in MI's and other preventive measures for patients with atrial fibrillation. An INR of 2.5 to 3.5 is recommended for patients with prosthetic heart valves (Ortel, 1995).

    Using the INR in other medical conditions, such as coagulopathy or liver disease has not been deemed appropriate as of this time, because INR was originally developed using anticoagulated patient populations. Despite its usefulness during routine monitoring of warfarin therapy, the use of INR for monitoring during the induction phase of therapy has not been fully supported (Hirsh & Poller, 1994). Reliability is lost during the initial days of therapy because of the varying rates of plasma clearance of vitamin K-dependent clotting factors. These factors are what the thromboplastin reagents are sensitive to and in turn what the INR and PTR are actually reporting. In addition, individual thromboplastin reagents vary in their sensitivities to the vitamin K-dependent clotting factors (Ortel, 1995).

    The INR system can be precise and valid when a sensitive thromboplastin and manual method of clot detection are used. However, it loses precision and accuracy when used to convert PT ratios obtained with less-sensitive thromboplastin reagents or when automated clot detection systems are used. These problems can be avoided by using reagents with low ISI's and proper calibration of machinery.

    Although the INR system is far from perfect, it is the only practical solution currently available. With all of its faults, it is much better than an unadjusted PT system. Although the clinician would like a system with little or no variability, the goal is unattainable unless a standardized sensitive reagent is universally adopted.


References:

Florell, S.R. & Rodgers, G.M. (December,1996). The PT and the pendulum. American Journal of Clinical Pathology, 699-700.
Hirsh, J. & Poller, L. (1994). International normalized ratio: A guide to understanding and correcting its problems. Archives of Internal Medicine, 154, 282-288.
National Center for Health Statistics, Cypress, B.K. (September, 1984). Patterns of ambulatory care in internal medicine. The National Ambulatory Care Survey, United States, January 1980-December 1981. Vital and Health Statistics, Series 13, no. 80. DHHS Pub. No. (PHS) 84-1741. Public Health Service. Washington D.C.: U.S. Government Printing Office.
Nichols, W. L. & Bowie, E. J. W. (1993). Standardization of the prothrombin time for monitoring orally administered anticoagulant therapy with use of the international normalized ration system. Mayo Clinical Procedure, 68, 897-898.
Ortel, L.B. (1995). International normalized ratio (INR); An improved way to monitor oral anticoagulant therapy. Nurse Practitioner, 20 (9), 15-22.


"Research Applied to Clinical Practice: International Normalized Ratio (INR)"
[http://ENW.org/Research-INR.htm]
is a webarticle by  Robert C. Knies, RN MSN CEN [bknies@stevenshealthcare.org]
©Robert C. Knies, RN MSN CEN
presented by Emergency Nursing World ! [http://ENW.org]
Tom Trimble, RN [Tom@ENW.org] ENW Webmaster
ENW
name, logos, and layout ©Tom Trimble, RN


 

 
 

Clinical Articles Special Articles

Links

2003 ASA
"Difficult Airway Practice Guidelines"

Airway 10 Commandments
Action Plan for Airway Hell!

Using Anesthesia Bags
Optimizing Mask Ventilation
Sedation Guidelines
Sedation Principles
Sedation Checklist

Aphorisms, Maxims, and Pearls
Discharge Instructions
I.V. Starts -Improving Your Odds!
Pediatric Hints -An ABC
Tips & Tricks -from Other Nurses
Manipulative Behaviors by Patients

Heat Emergencies
End Tidal CO2 Monitoring
in CPR: A Predictor of Outcome

Fix This Airway!
Crises in Airway Management

Bioterrorism References
Electrolytes
Headache & Stroke
Outsize Patients
--a big nursing challenge!

The Poisoned Patient
Respiratory Encounters (I Can't BREATHE! Part I)

Respiratory Encounters (I Can't BREATHE! Part II)

 

Internet Starter Set
Quick Subject Guide
Basic Desktop References
Medical Links
-  (Addiction Medicine to Gerontology)
Medical Links
- (Gov't to Medical Organizations)
Medical Links
- (Medical Records to Primary Care)
Medical Links
- [Psych. to Wilderness]
Nursing Links
[General]
Emergency Nursing Links
Pre-Hospital Links

- [Ambulance to EMS Web Pages]

Pre-Hospital Links
[Fire to Special Purpose Care Organizations]
Just for Fun Links
 
ENW !  urges help to
victims of recent disasters
American Red Cross  
donate page
 



supports and recommends

FREE EMERGENCY MEDICINE TALKS

   Emergency Medicine education for everyone.
 

MP3 files provided by: Joe Lex, MD
 


Fabulous Places!  --  Fabulous Conferences!
Check frequently for updates

   

Plan for the Year Ahead!  
Meetings & Symposia

                   Meetings of 2013

 
 
Clinical Research Behind the Scenes at ENW! The World of Emergency Nursing
Meet the Editor
Temperature Management
Gastric Decontamination

Thermometry in Acute Care
Latest Research in Resuscitation

Septic Children
ACT
INR
Carbon Monoxide
Malignant Hyperthermia
Geriatric Thermoregulation
SSRI's
"
Orthostatics"
NG Tubes
RSV
Defibrillation
Disclaimer  Applies to all portions of this site!

Policies of this Website

Information for Authors

The Emergency Nursing
& Emergency Nursing World ! FAQ


ENW is Listed@

What's This All About?

Tom Trimble's Tale
Library of Resources & Solutions
CPEN Review - Putting
 It All Together

Bedlam Among the Bedpans
Veinlite EMS
Body Piercing Removal Kit
& Training Program

Emergency Nursing 5-Tier
Triage Protocols
Emergency Newborn Care
Quick Reference to Triage
Quick-E Guides
The Emergency Nursing "Cool Web-Find!"
Honor Gallery of Previous Winners
An 1895 Look At Nursing
Beatitudes For Leaders
E-Mail Lists & Usenet Groups

Emergency Nursing WebLinks
Emergi-Lexicon
Em-Nsg-L: The Emergency Nursing List
Humor
Night-Shift Survival Tips
Old-Aid -Archaic & Obsolete
University-Level Emergency Nursing Education
Words & Thoughts
 
California ENA Website ENW! Supports ENA  

is now
http://www.CalENA.US

We Support

Use this button to
go to ENA's sit
e

Emergency
Nursing World !
is an independent entity and
NOT a component

of
ENA

 

 

 
Google


WWW ENW.org

Emergency

Nursing World !